Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
Ondas Holdings Inc. said it has priced an upsized $150 million public offering of common stock at $3.25 a share. The telecom-equipment maker did not disclose the number of shares, but the pricing implies roughly 46 million new shares will be issued, expanding its outstanding float. The low offering price sent the stock about 18% lower in early trading on Wednesday, as investors absorbed the additional supply. Ondas said the proceeds will go toward general corporate purposes, including potential acquisitions and working-capital needs. Despite the sell-off, Lake Street Capital Markets raised its price target on the company to $5 from $2.50 and reiterated a Buy rating, arguing the cash infusion should strengthen the balance sheet and support product development.
$TRV -Citi initiates Travelers coverage at Neutral $291 target - $TSHA -Wells Fargo raises Taysha Gene Therapies target to $8 from $7.50 Overweight - $UTHR -UBS raises United Therapeutics target to $415 from $385 Buy - $VERU -Raymond James lowers Veru target to $20 from $30
$SLDB -Wedbush lowers Solid Biosciences target to $14 from $17 Outperform - $SNOW -UBS lowers Snowflake target to $250 from $265 Buy - $SSTI -Lake Street lowers SoundThinking target to $19 from $20 Buy - $STOK -Wedbush raises Stoke Therapeutics target to $22 from $16 Outperform -
$RNR -Citi initiates RenaissanceRe coverage Buy $288 target - $RPAY -DA Davidson lowers Repay target to $10 from $12 Buy -UBS raises target to %.75 from $4.50 Neutral - $RYAN -Citi initiates Ryan Specialty coverage at Buy $74 target -
